本頁面由Tiger Trade Technology Pte. Ltd.提供服務

Atea Pharmaceuticals, Inc.

3.20
0.0000
成交量:14.41萬
成交額:45.66萬
市值:2.50億
市盈率:-1.81
高:3.21
開:3.21
低:3.11
收:3.20
52周最高:4.02
52周最低:2.46
股本:7,812.68萬
流通股本:6,000.97萬
量比:0.61
換手率:0.24%
股息:- -
股息率:- -
每股收益(TTM):-1.7696
每股收益(LYR):-1.9983
淨資產收益率:-37.98%
總資產收益率:-23.86%
市淨率:0.79
市盈率(LYR):-1.60

資料載入中...

2024/02/02

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/02/02

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/02/02

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/02/02

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/02/02

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2023/11/28

超過5%披露

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
2023/11/09

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2023/11/09

重要事件披露

Form 8-K - Current report
2023/10/02

超過5%披露

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
2023/08/09

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2023/08/08

重要事件披露

Form 8-K - Current report
2023/06/22

重要事件披露

Form 8-K - Current report
2023/05/22

超過5%披露

Form SC 13D - General statement of acquisition of beneficial ownership
2023/05/08

重要事件披露

8-K - Current report
2023/05/08

季度報告

10-Q - Quarterly report [Sections 13 or 15(d)]
2023/02/28

重要事件披露

8-K - Current report
2023/02/28

年度報告

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2023/02/10

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2023/02/10

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2023/02/09

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals